These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 475762)

  • 41. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficiency of serum C1 subcomponents and low functional activity of C1- inhibitor in a patient with urticaria and cryoglobulinemia.
    Lamas AM; Arnold PI; Schultz DR
    Am J Med; 1992 Apr; 92(4):445-6. PubMed ID: 1558093
    [No Abstract]   [Full Text] [Related]  

  • 43. Regulation of the synthesis of C1 subcomponents and C1-inhibitor.
    Gulati P; Lemercier C; Guc D; Lappin D; Whaley K
    Behring Inst Mitt; 1993 Dec; (93):196-203. PubMed ID: 8172568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biochemical data on C1 intrinsic activation (author's transl)].
    Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
    Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The identification of a previously unrecognized subcomponent of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement and C1q binding substances in otitis media.
    Prellner K; Nilsson NI; Johnson U; Laurell AB
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):129-32. PubMed ID: 6778293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C1 dissociation in serum: estimation of free C1q by electroimmunoassay.
    Sjöholm AG; Mårtensson U; Laurell AB
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):161-8. PubMed ID: 3876685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
    Siegel RC; Schumaker VN; Poon PH
    J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunofluorescence studies on the subcomponents of the first component of complement (C1): detection of C1q and C1s in different cells of biopsy material and on human as well as on guinea pig peritoneal macrophages.
    Loos M; Storz R; Müller W; Lemmel EM
    Immunobiology; 1981; 158(3):213-24. PubMed ID: 7011949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.
    Sim RB; Porter RR; Reid KB; Gigli I
    Biochem J; 1977 May; 163(2):219-27. PubMed ID: 869924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Functions and structure of complement inactivators in plasma. 1). C1 inhibitor].
    Yonemasu K
    Nihon Rinsho; 1988 Sep; 46(9):1899-903. PubMed ID: 3266510
    [No Abstract]   [Full Text] [Related]  

  • 60. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
    Loos M; Colomb M
    Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.